TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer.
about
Top2a identifies and provides epigenetic rationale for novel combination therapeutic strategies for aggressive prostate cancer.Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels.Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells.Probing the prostate tumour microenvironment II: Impact of hypoxia on a cell model of prostate cancer progression.Overexpression of Topoisomerase 2-Alpha Confers a Poor Prognosis in Pancreatic Adenocarcinoma Identified by Co-Expression Analysis.Cellular determinants and microenvironmental regulation of prostate cancer metastasis.Pim kinase isoforms: devils defending cancer cells from therapeutic and immune attacks.Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer.Prognostic effect of class III β-tubulin and Topoisomerase-II in patients with advanced thymic carcinoma who received combination chemotherapy, including taxanes or topoisomerase-II inhibitors.Determination of synthetic lethal interactions to provide therapeutic direction to end aggressive prostate cancer.Molecular determinants of prostate cancer metastasis.Copy number variation and high expression of DNA topoisomerase II alpha predict worse prognosis of cancer: a meta-analysis.Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responsesIdentification of genes and analysis of prognostic values in nonsmoking females with non-small cell lung carcinoma by bioinformatics analyses
P2860
Q35550192-940C1AA4-26AD-43CD-B55B-529FFB9850B9Q36355909-55425558-3C0C-4D28-9F74-F7750EC37B3EQ36414352-3BE8940B-506B-4729-BDFB-43327B540347Q37716544-BFCD6DF1-832C-4C0B-8137-98DB0BF68DA1Q38429740-40D0821D-D927-483B-BE6B-6B10464F9701Q38730590-7FB3C433-107A-494A-B8E7-12503A794F9BQ38960311-72E7651F-19DE-49F1-8022-BBFC2F7A97F3Q41009634-89A00722-CBB3-49F4-8C6A-AEF5CCFF15BDQ41143898-49779509-7E77-4795-9D13-8FE533C3F94CQ43969195-DCC2A65A-3D48-47DC-8FB2-11DB5F720CEDQ47103669-AD0B390F-0FDD-4F46-97AA-8999528CA0BEQ55396428-62D0A137-F78E-4B34-9C88-C8E8B2D4D265Q57106289-813E4C5C-7238-4294-BDCB-9F4E2869EC23Q57817336-4248C34A-FA84-49DC-8AF0-CF124EA75974
P2860
TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
TOP2Ahigh is the phenotype of ...... stem cells in prostate cancer.
@ast
TOP2Ahigh is the phenotype of ...... stem cells in prostate cancer.
@en
TOP2Ahigh is the phenotype of ...... stem cells in prostate cancer.
@nl
type
label
TOP2Ahigh is the phenotype of ...... stem cells in prostate cancer.
@ast
TOP2Ahigh is the phenotype of ...... stem cells in prostate cancer.
@en
TOP2Ahigh is the phenotype of ...... stem cells in prostate cancer.
@nl
prefLabel
TOP2Ahigh is the phenotype of ...... stem cells in prostate cancer.
@ast
TOP2Ahigh is the phenotype of ...... stem cells in prostate cancer.
@en
TOP2Ahigh is the phenotype of ...... stem cells in prostate cancer.
@nl
P2093
P2860
P356
P1433
P1476
TOP2Ahigh is the phenotype of ...... stem cells in prostate cancer
@en
P2093
Helen He Zhu
Huiming Xu
Mingliang Chu
Wei-Qiang Gao
Wenqi Chen
Xuefeng Li
Yunying Liu
Yuxiang Fang
P2860
P304
P356
10.18632/ONCOTARGET.2411
P407
P577
2014-10-01T00:00:00Z